干细胞/祖细胞介导的牙髓组织再生:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE、Cochrane CENTRAL和EMBASE至2019年1月,纳入8项动物实验(82只动物、336个实验性牙髓缺损)和1项人体试验(40人、40个牙髓缺损),比较干细胞/祖细胞移植与不移植对牙髓组织再生的影响。结果显示移植组牙髓组织再生显著增加(SDM 6.29,95%CI 3.78-8.80),但证据质量极低,临床常规应用尚不可及。
要点
- 干细胞/祖细胞移植可显著促进牙髓组织再生(SDM 6.29,95%CI 3.78-8.80)。
- 证据主要来自动物实验,偏倚风险高,人体数据有限。
- 牙髓活力和根尖愈合数据稀疏且不一致,证据质量极低。
核心结论
- 干细胞/祖细胞移植在牙髓再生方面显示前景,但临床常规应用尚不可及。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Cochrane CENTRAL和EMBASE至2019年1月。
- 纳入8项动物实验(82只动物、336个实验性牙髓缺损)和1项人体试验(40人、40个牙髓缺损)。
- 纳入随机对照试验(RCT)或对照临床试验(CCT),比较干细胞/祖细胞移植与不移植。
主要发现
- 干细胞/祖细胞移植组牙髓组织再生显著高于对照组(SDM 6.29,95%CI 3.78-8.80)。
- 牙髓活力和根尖愈合数据稀疏且不一致。
- 研究间异质性大,存在发表偏倚,主要采用间接替代结局指标。
关键数值与推荐
- 主要结局为组织学确定的牙髓组织再生,次要结局为牙髓活力和根尖愈合。
- 使用SYRCLE指南和修订版Cochrane偏倚风险工具(RoB 2.0)评估偏倚风险。
- 合并标准化均数差(SDM)和95%置信区间(95%CI)采用随机效应Meta分析。
临床怎么用
- 干细胞/祖细胞移植可能促进牙髓再生,但当前证据不足以支持临床常规应用。
- 需进一步开展包含功能性牙髓再生结局的研究。
局限性
- 多数动物研究偏倚风险高,人体试验存在「一些担忧」。
- 牙髓活力和根尖愈合数据稀疏且不一致。
- 研究间异质性大,存在发表偏倚,主要采用间接替代结局指标。
- 总体证据强度极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stem/progenitor cell-mediated pulpal regeneration could represent a promising therapeutic alternative in the field of clinical endodontics. AIM: The present study aimed to systematically assess and meta-analyse dental pulpal tissue regeneration, pulpal vitality and apical healing after the transplantation of stem/progenitor cells versus no transplantation. DATA SOURCES: MEDLINE, Cochrane CENTRAL and EMBASE were searched up to January 2019 for animal experiments and human trials evaluating the pulpal transplantation of stem/progenitor cells. Cross-referencing and hand search were additionally performed. STUDY ELIGIBILITY CRITERIA, PARTICIPANTS AND INTERVENTIONS: Based on randomized controlled clinical trials (RCTs) or controlled clinical trials (CCTs), conducted in animals or humans, the effect of the transplantation of stem/progenitor cells compared to no transplantation on pulpal tissue regeneration, pulpal vitality and apical healing was examined. STUDY APPRAISAL AND SYNTHESIS METHODS: The primary outcome was histologically determined pulpal tissue regeneration, whilst pulpal vitality and apical healing were secondary outcomes. The SYstematic Review Centre for Laboratory animal Experimentation (SYRCLE) guidelines and the revised Cochrane risk of bias tool (RoB 2.0) were used for risk-of-bias assessment. Pooled standardized differences in means (SDM) and 95% confidence intervals (95% CI) were calculated using random-effects meta-analyses. RESULTS: From 2834 identified articles, eight animal experiments (82 animals with 336 experimental pulpal defects) and one human trial (40 humans with 40 pulpal defects) were included. Risk of bias of most animal studies was high, whilst the human trial revealed 'some concerns'. Stem/progenitor cell-transplanted pulps demonstrated significantly increased pulpal tissue regeneration compared with controls (SDM [95%CI]: 6.29 [3.78-8.80]). LIMITATIONS: Data on pulpal vitality and apical healing were sparse and inconsistent. Heterogeneity across studies was substantial, publication bias was present, and mainly indirect, surrogate outcome measures were applied. The overall strength of evidence was very low. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: The transplanation of stem/progenitor cells shows promise for pulp regeneration, whilst clinical routine application is still not in reach. Further investigations, employing a comprehensive set of outcomes including those demonstrating functional pulp regeneration relevant for patient-centred care, are required.
引用
- Fawzy El-Sayed KM, Ahmed GM, Abouauf EA, et al. Stem/progenitor cell-mediated pulpal tissue regeneration: a systematic review and meta-analysis. Int Endod J. 2019. PMID: 31232460. doi:10.1111/iej.13177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。